Apr22021 CDI to Join Industry Stakeholders to Increase Public Awareness of Irritable Bowel Syndrome during IBS Awareness Month and World IBS Day Read more
Feb182021 Breath Testing 101: Learn Everything You Need to Know Before you Prescribe a Breath Test to Your Patient Read more
Feb32021 IBSchek® Granted PLA Code from AMA; CDI to Now Accept Insurance, Providing More Patients At-Home Access Read more
Jan282021 Hydrogen and Methane Breath Testing May Play Important Role In Patients Being Considered for Antireflux Surgery Read more
Jan142021 American College of Gastroenterology Issues Clinical Guidelines for IBS Diagnostics & Treatment Read more
Nov182020 CDI Co-Hosts Webinar with Epicured on Trends & Best Practices for Diagnosing & Treating Functional GI Disorders Read more
Sep172020 Intestinal Methane – Breath Testing Results for Extremely High Methane Production Read more
Jul212020 COVID-19, Aerosolization, and the Impact on Diagnostic Plans for Patients Presenting with GI-Related Symptoms Read more
Mar272020 COVID-19 Response: CDI Commits to Continuity of Care for Functional GI Patients During Time of Uncertainty Read more
Dec202019 CDI Announces Participation in the U.S Department of Veterans Affairs Community Care Network Read more
Jan52019 CDI Announces Its Participation in the Blue Cross Blue Shield of Massachusetts Network Read more
May12018 First Clinically Validated Blood Test for Diagnosing Diarrhea-Predominant and Mixed-Type Irritable Bowel Syndrome Read more
Jan302018 CDI Teams up With PGA Golfer Rob Oppenheim to Drive Awareness of Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO) Read more
May92017 Commonwealth Diagnostics Presents Evidence to Support Improved Testing Methods to Facilitate Diagnosis of Irritable Bowel Syndrome Read more
